795 related articles for article (PubMed ID: 14635018)
21. Characterization of an acyclovir-resistant herpes simplex virus type 2 strain isolated from a premature neonate.
Oram RJ; Marcellino D; Strauss D; Gustafson E; Talarico CL; Root AK; Sharma PL; Thompson K; Fingeroth JD; Crumpacker C; Herold BC
J Infect Dis; 2000 Apr; 181(4):1458-61. PubMed ID: 10762577
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of virus-encoded thymidine kinase suppresses herpes simplex virus replication in vitro and in vivo.
Watkins AM; Dunford PJ; Moffatt AM; Wong-Kai-In P; Holland MJ; Pole DS; Thomas GM; Martin J; Roberts NA; Mulqueen MJ
Antivir Chem Chemother; 1998 Jan; 9(1):9-18. PubMed ID: 9875372
[TBL] [Abstract][Full Text] [Related]
23. Identification and characterization of acyclovir-resistant clinical HSV-1 isolates from children.
Wang Y; Wang Q; Zhu Q; Zhou R; Liu J; Peng T
J Clin Virol; 2011 Oct; 52(2):107-12. PubMed ID: 21778105
[TBL] [Abstract][Full Text] [Related]
24. Genotypic detection of acyclovir-resistant HSV-1: characterization of 67 ACV-sensitive and 14 ACV-resistant viruses.
Frobert E; Cortay JC; Ooka T; Najioullah F; Thouvenot D; Lina B; Morfin F
Antiviral Res; 2008 Jul; 79(1):28-36. PubMed ID: 18336925
[TBL] [Abstract][Full Text] [Related]
25. Rapid determination of antiviral drug susceptibility of herpes simplex virus types 1 and 2 by real-time PCR.
Thi TN; Deback C; Malet I; Bonnafous P; Ait-Arkoub Z; Agut H
Antiviral Res; 2006 Mar; 69(3):152-7. PubMed ID: 16388859
[TBL] [Abstract][Full Text] [Related]
26. Susceptibility to acyclovir of herpes simplex virus isolates obtained between 1977 and 1996 in Japan.
Hasegawa T; Kawana T; Okuda T; Horii M; Tsukada T; Shiraki K
J Med Virol; 2001 Jan; 63(1):57-63. PubMed ID: 11130888
[TBL] [Abstract][Full Text] [Related]
27. Latent acyclovir-resistant herpes simplex virus type 1 in trigeminal ganglia of immunocompetent individuals.
van Velzen M; van Loenen FB; Meesters RJ; de Graaf M; Remeijer L; Luider TM; Osterhaus AD; Verjans GM
J Infect Dis; 2012 May; 205(10):1539-43. PubMed ID: 22457282
[TBL] [Abstract][Full Text] [Related]
28. Nucleotide sequence of thymidine kinase gene of sequential acyclovir-resistant herpes simplex virus type 1 isolates recovered from a child with Wiskott-Aldrich syndrome: evidence for reactivation of acyclovir-resistant herpes simplex virus.
Saijo M; Suzutani T; Itoh K; Hirano Y; Murono K; Nagamine M; Mizuta K; Niikura M; Morikawa S
J Med Virol; 1999 Aug; 58(4):387-93. PubMed ID: 10421406
[TBL] [Abstract][Full Text] [Related]
29. Intracellular uptake of thymidine and antiherpetic drugs for thymidine kinase-deficient mutants of herpes simplex virus type 1.
Bae PK; Kim JH; Kim HS; Chung IK; Paik SG; Lee CK
Antiviral Res; 2006 Jul; 70(3):93-104. PubMed ID: 16546268
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of an aqueous Pelargonium sidoides extract against herpesvirus.
Schnitzler P; Schneider S; Stintzing FC; Carle R; Reichling J
Phytomedicine; 2008 Dec; 15(12):1108-16. PubMed ID: 18691858
[TBL] [Abstract][Full Text] [Related]
31. Anti-herpes simplex virus activity of moronic acid purified from Rhus javanica in vitro and in vivo.
Kurokawa M; Basnet P; Ohsugi M; Hozumi T; Kadota S; Namba T; Kawana T; Shiraki K
J Pharmacol Exp Ther; 1999 Apr; 289(1):72-8. PubMed ID: 10086989
[TBL] [Abstract][Full Text] [Related]
32. Acyclovir-resistant herpes simplex virus type 1 in intra-ocular fluid samples of herpetic uveitis patients.
van Velzen M; Missotten T; van Loenen FB; Meesters RJ; Luider TM; Baarsma GS; Osterhaus AD; Verjans GM
J Clin Virol; 2013 Jul; 57(3):215-21. PubMed ID: 23582986
[TBL] [Abstract][Full Text] [Related]
33. Efficacy of orally administered Lobelia chinensis extracts on herpes simplex virus type 1 infection in BALB/c mice.
Kuo YC; Lee YC; Leu YL; Tsai WJ; Chang SC
Antiviral Res; 2008 Nov; 80(2):206-12. PubMed ID: 18621082
[TBL] [Abstract][Full Text] [Related]
34. A new homodimer of aciclovir as a prodrug with increased solubility and antiviral activity.
Brandi G; Rossi L; Schiavano GF; Millo E; Magnani M
Int J Antimicrob Agents; 2009 Aug; 34(2):177-80. PubMed ID: 19394201
[TBL] [Abstract][Full Text] [Related]
35. Emergence of resistance to carbocyclic oxetanocin G in herpes simplex virus type 1 and genetic analysis of resistant mutants.
Hu N; Shiota H
Acta Pharmacol Sin; 2004 Jul; 25(7):921-6. PubMed ID: 15210066
[TBL] [Abstract][Full Text] [Related]
36. The synergistic effects of betulin with acyclovir against herpes simplex viruses.
Gong Y; Raj KM; Luscombe CA; Gadawski I; Tam T; Chu J; Gibson D; Carlson R; Sacks SL
Antiviral Res; 2004 Nov; 64(2):127-30. PubMed ID: 15498608
[TBL] [Abstract][Full Text] [Related]
37. Thymidine kinase mutations conferring acyclovir resistance in herpes simplex type 1 recombinant viruses.
Sergerie Y; Boivin G
Antimicrob Agents Chemother; 2006 Nov; 50(11):3889-92. PubMed ID: 16982796
[TBL] [Abstract][Full Text] [Related]
38. Screening of herpes simplex virus type 1 isolates for acyclovir resistance using DiviTum® assay.
Sauerbrei A; Vödisch S; Bohn K; Schacke M; Gronowitz S
J Virol Methods; 2013 Mar; 188(1-2):70-2. PubMed ID: 23246510
[TBL] [Abstract][Full Text] [Related]
39. Anti-HSV activity of digitoxin and its possible mechanisms.
Su CT; Hsu JT; Hsieh HP; Lin PH; Chen TC; Kao CL; Lee CN; Chang SY
Antiviral Res; 2008 Jul; 79(1):62-70. PubMed ID: 18353452
[TBL] [Abstract][Full Text] [Related]
40. Penciclovir is a potent inhibitor of feline herpesvirus-1 with susceptibility determined at the level of virus-encoded thymidine kinase.
Hussein IT; Menashy RV; Field HJ
Antiviral Res; 2008 Jun; 78(3):268-74. PubMed ID: 18325606
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]